Role of DNA repair in the mechanisms of cell resistance to alkylating agents and cisplatin.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

9 citing papers in PubMed, 53 citations in OpenAlex.

1. Metformin enhances the radiosensitizing effect of cisplatin in non-small cell lung cancer cell lines with different cisplatin sensitivities.Scientific reports · 2019
   Article
2. Cisplatin sensitizes cancer cells to ionizing radiation via inhibition of nonhomologous end joining.Molecular cancer research : MCR · 2005
   Article
3. Sensitization of human malignant glioma cell lines to tumor necrosis factor-induced apoptosis by cisplatin.Journal of neuro-oncology · 2001
   Article
4. Cisplatin resistant glioblastoma cells may have increased concentration of urokinase plasminogen activator and plasminogen activator inhibitor type 1.Journal of neuro-oncology · 1999
   Article
5. In vitro circumvention of cisplatin resistance by the novel sterically hindered platinum complex AMD473.British journal of cancer · 1998
   Article
6. Combination effects of poly(ADP-ribose) polymerase inhibitors and DNA-damaging agents in ovarian tumor cell lines--with special reference to cisplatin.Journal of cancer research and clinical oncology · 1996
   Article
7. Repair analysis of 4-hydroperoxycyclophosphamide-induced DNA interstrand crosslinking in the c-myc gene in 4-hydroperoxycyclophosphamide-sensitive and -resistant medulloblastoma cell lines.Cancer chemotherapy and pharmacology · 1996
   Article
8. Morphonuclear characterization of drug resistance by means of digital cell-image analysis: an in vitro assessment.Cancer chemotherapy and pharmacology · 1995
   Article
9. Modulation of resistance to cisplatin by amphotericin B and aphidicolin in human larynx carcinoma cells.Cancer chemotherapy and pharmacology · 1995
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors at 2 institutions in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as